Skip to main content
. 2022 Jun 23;56(5):794–801. doi: 10.1111/apt.17092

FIGURE 1.

FIGURE 1

Disease outcomes at 12 months in children with moderate–severe disease who were eligible and ineligible for inclusion in the original randomised controlled trials. Normal ESR <25 mm/h; normal CRP <0.5 mg/dl. SFR, steroid free remission.